Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1968 1
1969 1
1970 1
1971 1
1979 1
1981 2
1982 1
1983 2
1984 1
1985 1
1987 2
1989 1
1990 1
1991 1
1995 2
2003 1
2005 2
2006 1
2007 2
2008 2
2009 1
2010 3
2011 2
2012 2
2013 2
2014 1
2015 2
2016 6
2017 2
2018 2
2019 4
2020 6
2021 3
2022 8
2023 5
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.
Le Pechoux C, Pourel N, Barlesi F, Lerouge D, Antoni D, Lamezec B, Nestle U, Boisselier P, Dansin E, Paumier A, Peignaux K, Thillays F, Zalcman G, Madelaine J, Pichon E, Larrouy A, Lavole A, Argo-Leignel D, Derollez M, Faivre-Finn C, Hatton MQ, Riesterer O, Bouvier-Morel E, Dunant A, Edwards JG, Thomas PA, Mercier O, Bardet A. Le Pechoux C, et al. Among authors: boisselier p. Lancet Oncol. 2022 Jan;23(1):104-114. doi: 10.1016/S1470-2045(21)00606-9. Epub 2021 Dec 15. Lancet Oncol. 2022. PMID: 34919827 Clinical Trial.
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
Tao Y, Sun XS, Pointreau Y, Le Tourneau C, Sire C, Kaminsky MC, Coutte A, Alfonsi M, Calderon B, Boisselier P, Martin L, Miroir J, Ramee JF, Delord JP, Clatot F, Rolland F, Villa J, Magne N, Elicin O, Gherga E, Nguyen F, Lafond C, Bera G, Calugaru V, Geoffrois L, Chauffert B, Damstrup L, Crompton P, Ennaji A, Gollmer K, Nauwelaerts H, Bourhis J. Tao Y, et al. Among authors: boisselier p. Eur J Cancer. 2023 Apr;183:24-37. doi: 10.1016/j.ejca.2022.12.015. Epub 2023 Jan 9. Eur J Cancer. 2023. PMID: 36796234 Free article. Clinical Trial.
[Treatment of oligometastatic or oligoprogression cancer].
Bourgier C, Latorzeff I, Fenoglietto P, Boisselier P, Charissoux M, Llacer C, Lemanski C, Riou O, Farcy-Jacquet MP, Azria D. Bourgier C, et al. Among authors: boisselier p. Cancer Radiother. 2019 Oct;23(6-7):482-485. doi: 10.1016/j.canrad.2019.07.143. Epub 2019 Sep 5. Cancer Radiother. 2019. PMID: 31495737 Review. French.
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
Sun XS, Tao Y, Le Tourneau C, Pointreau Y, Sire C, Kaminsky MC, Coutte A, Alfonsi M, Boisselier P, Martin L, Miroir J, Ramee JF, Delord JP, Clatot F, Rolland F, Villa J, Magne N, Elicin O, Gherga E, Nguyen F, Lafond C, Bera G, Calugaru V, Geoffrois L, Chauffert B, Zubel A, Zanna C, Brienza S, Crompton P, Rouits E, Gollmer K, Szyldergemajn S, Bourhis J. Sun XS, et al. Among authors: boisselier p. Lancet Oncol. 2020 Sep;21(9):1173-1187. doi: 10.1016/S1470-2045(20)30327-2. Epub 2020 Aug 3. Lancet Oncol. 2020. PMID: 32758455 Clinical Trial.
[Radioanatomy of rhinopharyngeal carcinoma].
Braccini AL, Haberer-Guillerm S, Azria D, Garrel R, Pierre G, Auge Y, Boisselier P. Braccini AL, et al. Among authors: boisselier p. Cancer Radiother. 2013 Nov;17(7):715-23. doi: 10.1016/j.canrad.2013.04.007. Epub 2013 Oct 25. Cancer Radiother. 2013. PMID: 24709383 Review. French.
Reply to Caccialanza et al.
Boisselier P, Thézénas S, Flori N, Vinches M, Bourhis J, Senesse P. Boisselier P, et al. Am J Clin Nutr. 2021 Apr 6;113(4):1054-1055. doi: 10.1093/ajcn/nqaa425. Am J Clin Nutr. 2021. PMID: 33822866 Free article. No abstract available.
Head and neck carcinoma of unknown primary.
Kennel T, Garrel R, Costes V, Boisselier P, Crampette L, Favier V. Kennel T, et al. Among authors: boisselier p. Eur Ann Otorhinolaryngol Head Neck Dis. 2019 Jun;136(3):185-192. doi: 10.1016/j.anorl.2019.04.002. Epub 2019 Apr 17. Eur Ann Otorhinolaryngol Head Neck Dis. 2019. PMID: 31005456 Free article. Review.
[Paranasal sinus carcinoma].
Vieillot S, Boisselier P, Aillères N, Hay MH, Dubois JB, Azria D, Fenoglietto P. Vieillot S, et al. Among authors: boisselier p. Cancer Radiother. 2010 Nov;14 Suppl 1:S52-60. doi: 10.1016/S1278-3218(10)70008-1. Cancer Radiother. 2010. PMID: 21129670 French.
81 results